Reading Our Genome is Tough, But Epigenetics is Giving Us Valuable Clues
By Marcus Woo,
Wired
| 02. 19. 2015
Untitled Document
When scientists sequenced the human genome a decade ago, they hoped to unlock the code of life, the sequence of molecules lined up in every cell that, summed together, made a person a person—and possibly reveal new ways to understand and treat diseases. But the results turned out to be opaque. Biologist Eric Lander, who helped lead the effort, famously summed up the results in seven words: “Genome: Bought the book; hard to read.”
So the research community went looking for CliffsNotes. A decade ago scientists started looking into the “epigenome,” chemical modifications to DNA that tell cells which genes to turn on or turn off. This week that project got a huge data dump—24 journal articles laying out what the genomicists know so far about 111 different cell types, the inner lives of brains, hearts, blood, and skin. “It is giving us a view of the living, breathing genome in motion, as opposed to a static picture of DNA,” says Manolis Kellis, a computational biologist at MIT who worked on two of the new papers.
Just about every...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...